American Society of Plastic Surgeons
For Consumers

 Shop Home

 Home  Cart

Product Image

Journal CME Article: New Developments in the Management of Cutaneous Squamous Cell Carcinoma

Login Required
To add this product to your cart, please log in.

Member Price $25.00Non-Member Price $200.00 In Stock

Product Description

This continuing medical education article reviews the features, management, and prognosis of cutaneous squamous cell carcinoma with an emphasis on high-risk squamous cell carcinoma and data from the past 3 years. This review will discuss the primary tumor management, high-risk features of a squamous cell carcinoma, changes to the American Joint Committee on Cancer staging system, and the utility of sentinel lymph node biopsy, and critically review the evidence regarding adjuvant therapy. (Plast. Reconstr. Surg. 147: 492e, 2021.)

Learning Objectives
After viewing this course, the participant should be able to:
  1. List important prognostic features that affect cutaneous squamous cell carcinoma risk. 
  2. Summarize the changes to the AJCC Cancer Staging Manual, Eighth Edition, staging system for cutaneous squamous cell carcinoma. 
  3. Evaluate the draining nodal basin with appropriate imaging modalities. 
  4. Recommend adjuvant radiation therapy in the correct clinical setting for high-risk tumors. 
  5. Recognize the currently available treatments for advanced cutaneous squamous cell carcinoma.
Thomas J. Knackstedt, MD; Rebecca W. Knackstedt, MD PhD; Michelle Djohan, BS; Raisal Djohan, MD; Brian R. Gastman, MD; David R. Crowe, MD

Plastic and Reconstruction Surgery®Editors: 
Rod J. Rohrich, MD
James M. Stuzin, MD
Section Editors: 
Donald H. Lalonde, MD; John YS Kim, MD

Accreditation Information

AMA PRA Category 1 CreditTM:  1.0
Patient Safety Credit:  0.5
Media:  Journal Article, video
Release Date:  2/26/2021
Expiration Date:  2/26/2024
Estimated time to complete this course: 1 hour

*Course access ends on course expiration date

Directly provided by the American Society of Plastic Surgeons® (ASPS®)

Accreditation Statement
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. The authors have no disclosures. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Return Policy for Downloaded and Viewable Products
Products which are downloaded or viewable after purchase may not be returned. By placing an order you are agreeing to the product return terms and conditions set forth by this site. ASPS Shop Return Policy

Product Code: 30794